NTBL — Notable Labs Cashflow Statement
0.000.00%
Last trade - 00:00- $5.67m
- -$2.18m
- $0.31m
- 17
- 29
- 23
- 12
Annual cashflow statement for Notable Labs, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
R2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 20-F | 20-F | 20-F | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -19.4 | -24.2 | -29.9 | -32.3 | -11.3 |
| Depreciation | |||||
| Non-Cash Items | 2.47 | 1.73 | 1.98 | 2.26 | -2.01 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 2.62 | -2.08 | 1.7 | -2.61 | -0.698 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -13.1 | -23.4 | -25 | -31.6 | -13.7 |
| Capital Expenditures | -0.073 | -0.051 | -1.47 | -0.812 | -0.065 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -6.03 | 9.94 | -14 | 28.1 | 15.6 |
| Sale of Business | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | -6.1 | 9.89 | -15.5 | 27.3 | 15.5 |
| Financing Cash Flow Items | — | — | -2.2 | 0 | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -0.359 | 17.1 | 49.1 | 0.022 | 7.82 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -19.4 | 3.75 | 8.65 | -4.32 | 10.2 |